Literature DB >> 28869615

Acute and fatal cardiotoxicity following high-dose cyclophosphamide in a patient undergoing autologous stem cell transplantation for systemic sclerosis despite satisfactory cardiopulmonary screening.

M Martin1, L-M Fornecker2, L Marcellin3, E Mousseaux4, A Hij5, J A Snowden6,7, D Farge5, T Martin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28869615     DOI： 10.1038/bmt.2017.188

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

1.  Hematopoietic stem cell transplantation in systemic sclerosis: Yes!! BUT. . .

Authors:  Khitam A AlOdhaibi; John Varga; Daniel E Furst
Journal:  J Scleroderma Relat Disord       Date:  2020-11-18

Review 2.  Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity.

Authors:  Lars Michel; Tienush Rassaf; Matthias Totzeck
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 3.  Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation.

Authors:  Seth J Rotz; Thomas D Ryan; Salim S Hayek
Journal:  J Thromb Thrombolysis       Date:  2020-11-24       Impact factor: 2.300

Review 4.  Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?

Authors:  Madelon C Vonk
Journal:  J Scleroderma Relat Disord       Date:  2020-10-06

5.  Diagnosis of Simultaneous Atrial and Ventricular Mechanical Performance in Patients with Systemic Sclerosis.

Authors:  Mohammadbagher Sharifkazemi; Mohammadali Nazarinia; Alireza Arjangzade; Mohamad Goldust; Zahra Hooshanginezhad
Journal:  Biology (Basel)       Date:  2022-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.